FDA's Overreach on Compounded Peptides The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 can be taken orally or subcutaneously, and for most people there is no difference in efficacy.Yes, some people will notice one works better than the other. Yes, some people will claim that Peptide Therapy Regenerative Treatments at Blum Health